최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of pathology and translational medicine : JPTM, v.56 no.1, 2022년, pp.32 - 39
Lee, Ki Rim (Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea) , Koh, Jiwon (Department of Pathology, Seoul National University College of Medicine, Seoul, Korea) , Jeon, Yoon Kyung (Department of Pathology, Seoul National University College of Medicine, Seoul, Korea) , Kwon, Hyun Jung (Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea) , Lee, Jeong-Ok (Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea) , Paik, Jin Ho (Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea)
BackgroundPrimary adrenal (PA) diffuse large B cell lymphoma (DLBCL) was previously reported as an aggressive subset of DLBCL, but its genetic features were not sufficiently characterized. From our previous study of DLBCL with programmed death-ligand 1 (PD-L1) gene alterations, we focused on PD-L1 g...
1 Swerdlow SH Campo E Pileri SA The 2016 revision of the World Health Organization classification of lymphoid neoplasms Blood 2016 127 2375 90 26980727
2 Nagasaki J Togashi Y Sugawara T The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma Blood Adv 2020 4 4069 82 32870971
3 Xu-Monette ZY Zhou J Young KH PD-1 expression and clinical PD-1 blockade in B-cell lymphomas Blood 2018 131 68 83 29118007
4 Roemer MG Advani RH Ligon AH PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome J Clin Oncol 2016 34 2690 7 27069084
5 Ansell SM Lesokhin AM Borrello I PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma N Engl J Med 2015 372 311 9 25482239
6 Kwon HJ Yang JM Lee JO Lee JS Paik JH Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma J Transl Med 2018 16 320 30458835
7 Twa DD Chan FC Ben-Neriah S Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma Blood 2014 123 2062 5 24497532
8 Chapuy B Roemer MG Stewart C Targetable genetic features of primary testicular and primary central nervous system lymphomas Blood 2016 127 869 81 26702065
9 Cohen R Jonchere V De La Fouchardiere C Adrenal gland as a sanctuary site for immunotherapy in patients with microsatellite instability-high metastatic colorectal cancer J Immunother Cancer 2021 9 e001903 33579738
10 Mushtaq RR Gao D Raeburn C Tobin RP Robinson W Adrenal metastases in malignant melanoma, is it a privileged site? J Clin Oncol 2019 37 15 Suppl e21016
11 Rashidi A Fisher SI Primary adrenal lymphoma: a systematic review Ann Hematol 2013 92 1583 93 23771429
12 Kim YR Kim JS Min YH Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL) J Hematol Oncol 2012 5 49 22889180
13 Laurent C Casasnovas O Martin L Adrenal lymphoma: presentation, management and prognosis QJM 2017 110 103 9 27795295
14 Mozos A Ye H Chuang WY Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis Mod Pathol 2009 22 1210 7 19525926
15 Audrito V Serra S Stingi A PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p Oncotarget 2017 8 15894 911 28199980
16 Gao Q Wang XY Qiu SJ Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma Clin Cancer Res 2009 15 971 9 19188168
17 Hans CP Weisenburger DD Greiner TC Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray Blood 2004 103 275 82 14504078
18 Bardhan K Anagnostou T Boussiotis VA The PD1:PD-L1/2 pathway from discovery to clinical implementation Front Immunol 2016 7 550 28018338
19 Hudson K Cross N Jordan-Mahy N Leyland R The extrinsic and intrinsic roles of PD-L1 and its receptor PD-1: implications for immunotherapy treatment Front Immunol 2020 11 568931 33193345
20 Pasqualucci L Dalla-Favera R The genetic landscape of diffuse large B-cell lymphoma Semin Hematol 2015 52 67 76 25805586
21 Iqbal J Greiner TC Patel K Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma Leukemia 2007 21 2332 43 17625604
22 Peng C Hu Q Yang F Zhang H Li F Huang C BCL6-mediated silencing of PD-1 ligands in germinal center B cells maintains follicular T cell population J Immunol 2019 202 704 13 30567732
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.